Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 3577 | 1878 | 32.5 | 65% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 734 | 11922 | FLUID RESPONSIVENESS//HYDROXYETHYL STARCH//CARDIAC OUTPUT |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | HYDROXYETHYL STARCH | Author keyword | 176 | 53% | 12% | 230 |
| 2 | CRYSTALLOIDS | Author keyword | 30 | 37% | 3% | 65 |
| 3 | PLASMA SUBSTITUTES | Author keyword | 29 | 67% | 1% | 26 |
| 4 | HETASTARCH | Author keyword | 25 | 51% | 2% | 35 |
| 5 | PLASMA SUBSTITUTES THERAPEUTIC USE | Author keyword | 18 | 89% | 0% | 8 |
| 6 | VOLUME REPLACEMENT | Author keyword | 17 | 42% | 2% | 31 |
| 7 | BLOOD PROTEINS THERAPEUTIC USE | Author keyword | 17 | 100% | 0% | 8 |
| 8 | FLUID THERAPY | Author keyword | 13 | 15% | 4% | 77 |
| 9 | HES 130 04 | Author keyword | 12 | 86% | 0% | 6 |
| 10 | COLLOIDS THERAPEUTIC USE | Author keyword | 11 | 100% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | HYDROXYETHYL STARCH | 176 | 53% | 12% | 230 | Search HYDROXYETHYL+STARCH | Search HYDROXYETHYL+STARCH |
| 2 | CRYSTALLOIDS | 30 | 37% | 3% | 65 | Search CRYSTALLOIDS | Search CRYSTALLOIDS |
| 3 | PLASMA SUBSTITUTES | 29 | 67% | 1% | 26 | Search PLASMA+SUBSTITUTES | Search PLASMA+SUBSTITUTES |
| 4 | HETASTARCH | 25 | 51% | 2% | 35 | Search HETASTARCH | Search HETASTARCH |
| 5 | PLASMA SUBSTITUTES THERAPEUTIC USE | 18 | 89% | 0% | 8 | Search PLASMA+SUBSTITUTES+THERAPEUTIC+USE | Search PLASMA+SUBSTITUTES+THERAPEUTIC+USE |
| 6 | VOLUME REPLACEMENT | 17 | 42% | 2% | 31 | Search VOLUME+REPLACEMENT | Search VOLUME+REPLACEMENT |
| 7 | BLOOD PROTEINS THERAPEUTIC USE | 17 | 100% | 0% | 8 | Search BLOOD+PROTEINS+THERAPEUTIC+USE | Search BLOOD+PROTEINS+THERAPEUTIC+USE |
| 8 | FLUID THERAPY | 13 | 15% | 4% | 77 | Search FLUID+THERAPY | Search FLUID+THERAPY |
| 9 | HES 130 04 | 12 | 86% | 0% | 6 | Search HES+130+04 | Search HES+130+04 |
| 10 | COLLOIDS THERAPEUTIC USE | 11 | 100% | 0% | 6 | Search COLLOIDS+THERAPEUTIC+USE | Search COLLOIDS+THERAPEUTIC+USE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HETASTARCH | 152 | 73% | 6% | 116 |
| 2 | HYDROXYETHYL STARCH | 89 | 29% | 14% | 258 |
| 3 | VOLUME REPLACEMENT | 78 | 64% | 4% | 77 |
| 4 | LACTATED RINGERS SOLUTION | 51 | 38% | 6% | 106 |
| 5 | MODIFIED FLUID GELATIN | 48 | 76% | 2% | 34 |
| 6 | PENTASTARCH | 48 | 73% | 2% | 37 |
| 7 | HYDROXYETHYL STARCH 130 04 | 47 | 56% | 3% | 57 |
| 8 | 6 PERCENT | 40 | 66% | 2% | 38 |
| 9 | HES 130 04 | 37 | 73% | 2% | 29 |
| 10 | PLASMA SUBSTITUTES | 36 | 61% | 2% | 38 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation A Systematic Review and Meta-analysis | 2013 | 128 | 43 | 74% |
| Meta-analysis of high-versus low-chloride content in perioperative and critical care fluid resuscitation | 2015 | 8 | 60 | 52% |
| Hydroxyethyl Starches Different Products - Different Effects | 2009 | 138 | 112 | 85% |
| Human albumin administration in critically ill patients: systematic review of randomised controlled trials | 1998 | 497 | 29 | 79% |
| Safety of Modern Starches Used During Surgery | 2013 | 54 | 60 | 80% |
| Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function | 2010 | 75 | 67 | 73% |
| The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis | 2011 | 90 | 36 | 61% |
| Incidence of postoperative death and acute kidney injury associated with i.v. 6 hydroxyethyl starch use: systematic review and meta-analysis | 2014 | 17 | 44 | 68% |
| A Systematic Review of Third-Generation Hydroxyethyl Starch (HES 130/0.4) in Resuscitation: Safety Not Adequately Addressed | 2011 | 58 | 70 | 84% |
| Accumulation of hydroxyethyl starch in human and animal tissues: a systematic review | 2014 | 11 | 39 | 90% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ANESTHESIOL INTENS CARE B | 3 | 43% | 0.3% | 6 |
| 2 | CRIT CARE TRAUMA | 3 | 20% | 0.6% | 12 |
| 3 | CARDIAC VASC INTENS CARE UNIT | 2 | 67% | 0.1% | 2 |
| 4 | FLUID THER Y | 2 | 67% | 0.1% | 2 |
| 5 | AUSTRALIA NEW ZEALAND INTENS CARE | 2 | 50% | 0.2% | 3 |
| 6 | ANAESTHESIA INTENS CARE CUE MED | 1 | 100% | 0.1% | 2 |
| 7 | CHILD HLTH MONITORING UNIT | 1 | 30% | 0.2% | 3 |
| 8 | DISCIPLINE ACUTE CARE | 1 | 40% | 0.1% | 2 |
| 9 | MALCOLM FISHER INTENS CARE MED | 1 | 40% | 0.1% | 2 |
| 10 | COCHRANE INJURIES GRP | 1 | 15% | 0.3% | 6 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000131107 | HYPERTONIC SALINE//SMALL VOLUME RESUSCITATION//HEMORRHAGIC SHOCK |
| 2 | 0.0000128822 | HYPERVOLUMETRIC HEMODILUTION//NEUROL D4 5//HYPERVOLEMIC HEMODILUTION |
| 3 | 0.0000093339 | STRONG ION GAP//STRONG ION DIFFERENCE//ANION GAP |
| 4 | 0.0000079416 | PULSE DYE DENSITOMETRY//PULSE SPECTROPHOTOMETRY//CIRCULATING BLOOD VOLUME |
| 5 | 0.0000074502 | VOLUME KINETICS//FLUIDS IV//BLOOD HAEMODILUTION |
| 6 | 0.0000071909 | MASSIVE TRANSFUSION//THROMBOELASTOMETRY//THROMBOELASTOGRAPHY |
| 7 | 0.0000064154 | FLUID RESPONSIVENESS//STROKE VOLUME VARIATION//THERMODILUTION |
| 8 | 0.0000057737 | INTERSTITIAL FLUID VOLUME//MED MC787//TISSUE PLASMA CLEARANCE |
| 9 | 0.0000051475 | GRANULOCYTE TRANSFUSION//GRANULOCYTE TRANSFUSIONS//GRANULOCYTE CONCENTRATES |
| 10 | 0.0000049553 | SURVIVING SEPSIS CAMPAIGN//SEVERE SEPSIS//EARLY GOAL DIRECTED THERAPY |